
Disposable e-cigarettes are more toxic than traditional cigarettes, researchers say
Disposable electronic cigarettes that are popular with teenagers are more toxic than traditional cigarettes, researchers cautioned on Wednesday.
Researchers from the University of California at Davis found that, following a few hundred puffs, some vape pods and other e-cigarettes emit higher amounts of toxic metals than traditional cigarettes.
One of the e-cigarettes they studied released more lead during the course of a day than nearly 20 packs of traditional cigarettes. In humans, exposure to lead has been shown to result in reproductive issues, high blood pressure, hypertension, nerve disorders, muscle and joint pain, and memory and concentration problems in adults. In children, it can lead to hearing problems, slowed growth, headaches, learning and behavioral difficulties, lowered IQ, and damage to the brain and nervous system.
'Our study highlights the hidden risk of these new and popular disposable electronic cigarettes — with hazardous levels of neurotoxic lead and carcinogenic nickel and antimony — which stresses the need for urgency in enforcement,' Brett Poulin, an assistant professor at the university's Davis Department of Environmental Toxicology, said in a statement. 'These risks are not just worse than other e-cigarettes but worse in some cases than traditional cigarettes.'
Poulin was the senior author of the findings, which were published in the journal ACS Central Science.
To reach these conclusions, the scientists analyzed the metal and elements that exhibit properties of metals in seven types of disposable devices from three of the most popular brands. The brands included Esco Bar, Flum Pebble, and ELF Bar. The brands did not immediately reply to The Independent's requests for comment.
They activated the e-cigarettes and created between 500 and 1,500 puffs per device tested.
The authors found that some devices emitted 'surprisingly high' concentrations of lead and antimony, that levels of chromium, nickel, and antimony increased as the number of puffs increased, and that most of the disposable e-cigarettes tested released markedly higher amounts of metals and metalloids into vapors than earlier and refillable vapes.
Antimony is used in flame retardant, chromium is used in the production of stainless steel, and nickel is used in appliances and rechargeable batteries. Antimony is a hazardous substance that can cause dizziness, nausea, vomiting, liver and kidney damage, and a hole in the septum. Chromium exposure is also linked to kidney and liver damage, as well as respiratory cancer and perforated eardrums. Nickel can cause a variety of side effects on human health, such as allergy, cardiovascular and kidney diseases, lung fibrosis, and lung and nasal cancer. There are other chemicals in e-cigarettes that also may cause cancer.
Then, the researchers took the devices apart, hoping to trace the sources of the metals.
They saw that components in some devices that were made of leaded bronze alloy had leached into e-liquids in the cartridges and that nickel was being released from heating coils. Antimony was also in the unused e-liquids.
'We found that these disposable devices have toxins already present in the e-liquid, or they're leaching quite extensively from their components into e-liquids and ultimately transferred to the smoke,' Mark Salazar, a Ph.D. candidate in Poulin's lab and the study's first author, explained.
For daily users, vapors from three devices had nickel levels and two devices had antimony levels that exceeded cancer risk limits. Four of the devices had nickel and lead emissions that surpassed health-risk thresholds for illnesses besides cancer, such as neurological damage and respiratory diseases.
E-cigarette use has been tied to lung injuries, with more than 2,800 hospitalizations and 68 deaths reported between the summer of 2019 and February 2020, according to Yale Medicine.
Although most disposable e-cigarettes are illegal in the U.S., they remain available. Last week, the Supreme Court sided with companies in a ruling making it easier to sue over Food and Drug Administration decisions blocking their products from the market.
ELF Bar and Esco Bar have been the focus of Food and Drug Administration scrutiny. ELF Bar's website says it is not available in the U.S. and FLUM is illegal under California's retail flavor ban. To date, 34 tobacco- and menthol-flavored e-cigarette products and devices have been authorized by the Food and Drug Administration.
The majority of e-cigarette consumers are teens and young adults, including 1.63 million students, according to the Centers for Disease Control and Prevention. Like regular cigarettes, most e-cigarettes contain nicotine. Nicotine is highly addictive and can harm the parts of an adolescent's brain that control attention, learning, mood, and impulse control.
Last year, however, use among youth plummeted to the lowest level in a decade.
Still, the risks associated with using e-cigarettes remain, and young adults are at increased risk of lead exposure. The researchers noted that the market is outpacing science, heightening the need to enforce regulations around illegal e-cigarettes.
'Pediatric tobacco use and nicotine dependence are significant health concerns. Despite declines in cigarette use, youth still use tobacco products—including e-cigarettes—at high rates,' the American Academy of Pediatrics stresses.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Daily Mail
17 minutes ago
- Daily Mail
This is the terrifying truth about alternative cancer therapies - and what happened when I encountered the 'coaches' peddling the treatments that cost young women like Paloma their lives: LIZ O'RIORDAN
The message, from a stranger on Instagram, absolutely broke me. 'Dear Liz,' it began, 'I need to tell you about a friend with advanced breast cancer. She has spent thousands on restrictive diets and supplements, instead of having surgery and chemotherapy.' As a former breast surgeon who has had breast cancer three times, I'm used to people telling me about personal medical matters. I now write and speak regularly about the disease, trying to share evidence-based advice and help others navigate the minefield of misinformation online.


BBC News
2 hours ago
- BBC News
How dem make anti-venom from man wey snake bite 200 times
Di blood of one US man wey deliberately inject imsef wit snake venom for nearly twenty years don lead to "unparalleled" anti-venom, scientists tok. Antibodies find in Tim Friede blood don shown to protect against deadly doses from one wide range of species in animal tests. Current therapies gatz match di specific species of venomous snake wey bite anyone. But Oga Friede 18-year mission fit lead to ogbonge step of finding universal anti-venom against all snakebites - wey dey kill up to 140,000 pipo evri year and leave three times as many needing amputations or facing permanent disability. In total, Mr Friede don endure more dan 200 bites and more dan 700 injections of venom e prepare from some of di world deadliest snakes, including multiple species of mambas, cobras, taipans and kraits. E bin want build up im immunity to protect imsef wen e dey handle snakes, documenting im exploits on YouTube. But di former truck mechanic tok say e don "completely screw up" early on wen two cobra bites wey happun in quick succession leave am in coma. "I no wan die. I no wan lose one finger. I no wan miss work," e tell BBC. Oga Friede motivation na to develop beta therapies for di rest of di world, explaining: "E just become lifestyle and I just keep pushing and pushing and pushing as hard as I fit push - for di pipo wey dey 8,000 miles away from me wey don die from snakebite". 'I go love to get my hands on some of your blood' Currently dem dey make anti-venom by injecting small doses of snake venom into animals, such as horses. Dia immune system dey fight di venom by producing antibodies and dem go harvest am to use as therapy. But venom and anti-venom gatz dey closely matched becos di toxins for venomous bite no be di same from one species to anoda. Dem even get wide variety within di same species – anti-venom wey dem make from snakes from India dey less effective against di same species for Sri Lanka. One team of researchers begin dey search for one type of immune defence wey dem dey call broadly neutralising antibodies. Instead of targeting di part of toxin wey make am unique, dem dey target di part wey make am common to entire classes of toxin. Dat na wen Dr Jacob Glanville, chief executive of biotech company Centivax, come across Tim Friede. "Immediately I look say 'if anybody in di world don develop dis broadly neutralising antibodies, e go be am' and so I reach out," e tok. "Di first call, I be like 'dis fit dey awkward, but I go love get my hands on some of your blood'." Oga Friede agree and di work dey ethically approved becos di study go only take blood, rather dan give am more venom. Di research focus on elapids – one of di two families of venomous snakes – such as coral snakes, mambas, cobras, taipans and kraits. Elapids primarily use neurotoxins in dia venom, wey dey paralyse dia victim and e dey fatal wen dem stop di muscles e need to breathe. Researchers don pick 19 elapids identify by di World Health Organization as being among di deadliest snakes on di planet. Dem don begin to source for Oga Friede blood for protective defences. Dia work, dey detailed in di journal Cell, identify two broadly neutralising antibodies wey fit target two classes of neurotoxin. For experiments on mice, di cocktail mean say di animals bin survive deadly doses from 13 of di 19 species of venomous snake. Dem bin get partial protection against di remaining six. Dis na "unparalleled" breadth of protection, according to Dr Glanville, wey say e "likely cover a whole bunch of elapids for wey no get current anti-venom". Di team dey try to refine di antibodies further and see if adding fourth component fit lead to total protection against elapid snake venom. Di oda class of snake – di vipers – dey rely more on haemotoxins, wey dey attack di blood, rather dan neurotoxins. In total around one dozen broad classes of toxin in snake venom, wey also include cytotoxins dey directly kill cells. "I think in di next 10 or 15 years we go get somtin effective against each one of dis toxin classes," Prof Peter Kwong, one of di researchers for Columbia University, tok. And di hunt continue inside Oga Friede blood samples. "Tim antibodies dey really quite extraordinary - e bin teach im immune system to get dis veri, veri broad recognition," Prof Kwong tok. Di ultimate hope na to get either single anti-venom wey fit do evritin, or one injection for elapids and one for vipers. Prof Nick Casewell, na di head of di centre for snakebite research and interventions for di Liverpool School of Tropical Medicine - e tok say di breadth of protection report bin dey unusual and provide "strong piece of evidence" wey get feasible approach. "No doubt say dis work move di field forward in exciting direction." But e caution say "plenti work still dey to do" and di anti-venom still go need extensive testing bifor dem fit use am in pipo. But for Oga Friede, reaching dis stage "make me feel good". "I dey do somtin good for humanity and e bin dey veri important to me. I dey proud of am. E dey pretty cool."


Edinburgh Live
2 hours ago
- Edinburgh Live
Edinburgh baby's 'everyday symptom' at birthday party leads to devastating diagnosis
Our community members are treated to special offers, promotions and adverts from us and our partners. You can check out at any time. More info An Edinburgh dad has opened up on his family's devastation after their son's first birthday party led to a rare diagnosis. Marc Robson and his partner Melinda Garratt noticed their little boy Finley wasn't his usual self on the day of his party, and he started throwing up. Finley still wasn't feeling right the day after, so the family decided to call 111. Melinda, 31, and Marc, 32, said they were advised to visit a pharmacist. They were told it may be due to Finley transitioning from formula to cow's milk, though this didn't help his condition. After several trips to A&E, Finley began vomiting blood. Finley was eventually rushed to Newcastle's Royal Victoria Infirmary, where doctors found a tumour on his brain. Marc, who grew up in Edinburgh before starting a family in Newcastle, told Chronicle Live: "When we initially went to the RVI we thought it was going to be stomach issues, so hearing it was a tumour was very tough. "The only way I can describe it is it was almost like I wasn't in my own body when I was hearing it. It was a strange feeling. Melinda was in tears." Finley underwent an operation the following day which removed the majority of the tumour from his brain. Marc said: "They took him away from us at about 9.30am and we didn't see him again until 6.30pm. It was a very, very long day." Sign up for Edinburgh Live newsletters for more headlines straight to your inbox Approximately one week later the family received preliminary results which revealed the tumour could be one of four aggressive forms. And on Monday (June 23) the family received the heartbreaking news that Finley's tumour was the most aggressive of the four - an Atypical Teratoid Rhabdoid Tumor (ATRT) - an extremely rare form of brain cancer. Finley will now begin chemotherapy on Monday (June 30). Marc said: "I'm not sure if it has even sunk in fully for us yet. We've had quite a few sleepless nights. It's so hard to explain what it's like hearing the news. It's almost as if you're watching someone else get that news. "I think the next stage when he has the chemo is when it's going to hit the most. When we need to manage the treatment and his wellbeing even more than we already do. (Image: Melinda Garratt) "Contact with family and friends is going to be non-existent because of the side effects and his immune system going down. And when he loses his hair we've decided that we're going to shave it off to get it over and done with. "The doctor recommended we do that too because we didn't realise but when babies go through this they can easily choke on their hair when they're sleeping. We'll shave it off when we feel that his scars have healed from his operation." Finley will receive chemotherapy for the next five months before undergoing tests to see if it has been successful. Reflecting on how Finley has been coping with treatment, Marc said: "He doesn't talk other than he's recently started saying 'dada' so he can't really tell you what's wrong. "But you can tell he's been in a lot of pain since the operation, which is normal. After his first operation he didn't really move much, he was sleeping a lot and couldn't lift his head up so we had to hold him. Join Edinburgh Live's Whatsapp Community here and get the latest news sent straight to your messages. "He used to love rolling around but you could see that it was frustrating him when he was trying to move but he couldn't because he was in pain and he didn't quite understand why he was in pain." The couple have set up a GoFundMe page to help ease the financial burden they have already encountered since Finley became unwell. Marc, who works as a business development manager for a company which provides maintenance for care homes, is currently receiving full pay. However, he is unsure how much he will be able to work once Finley begins chemo. Melinda, who works for Lookers car sales company, is currently off work. As well as helping to manage bills and any unexpected costs that arise as the couple navigate treatments and time away from work, the money raised will also help the couple with hospital parking fees and travel expenses. For more information and how to donate visit the GoFundMe page here.